rhAngiostatin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rhAngiostatin, covering 2009-01-09 to 2009-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer [Phase 2]